Estimating the benefit of interferon therapy for individual patients with chronic hepatitis C.

被引：0
|
作者：
Yoshida, H
Tateishi, R
Arakawa, Y
Sata, M
Nishiguchi, S
Ishibashi, H
Fujiyama, S
Yamada, G
Yokosuka, O
Shiratori, Y
Omata, M
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Nihon Univ, Tokyo, Japan
[3] Kurume Univ, Kurume, Fukuoka 830, Japan
[4] Osaka City Univ, Osaka 558, Japan
[5] Nagasaki Med Ctr, Nagasaki, Japan
[6] Kumamoto Univ, Kumamoto 860, Japan
[7] Kawasaki Univ, Kawasaki Hosp, Okayama, Japan
[8] Chiba Univ, Chiba, Japan
[9] Okayama Univ, Okayama 7008530, Japan
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1005
引用
收藏
页码：641A / 641A
页数：1
相关论文
共 50 条
  • [1] Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
    Yoshida, H
    Tateishi, R
    Arakawa, Y
    Sata, M
    Fujiyama, S
    Nishiguchi, S
    Ishibashi, H
    Yamada, G
    Yokosuka, O
    Shiratori, Y
    Omata, M
    GUT, 2004, 53 (03) : 425 - 430
  • [2] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [3] Induction therapy with consensus interferon in the treatment of patients with chronic hepatitis C.
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, TF
    Lumeng, L
    McGill, JM
    Ness, RM
    Pintozzi, R
    Jones, B
    Lansford, C
    Maier, J
    Isenberg, M
    Mark, D
    Bennet, C
    Noar, M
    McCone, J
    Chasen, R
    Geissinger, B
    Goldstein, M
    Thuluvath, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1460 - A1460
  • [4] Interferon retreatment of patients with chronic hepatitis C.
    Picciotto, A
    Campo, N
    Brizzolara, R
    Sinelli, N
    GiudiciCipriani, A
    Ponassi, I
    Varagona, G
    Grasso, A
    DeLeo, P
    DeConca, V
    Mesiti, S
    Marenco, G
    Menardo, G
    Dodero, M
    Celle, G
    HEPATOLOGY, 1997, 26 (04) : 1160 - 1160
  • [5] Histological response of interferon therapy in chronic hepatitis C.
    Segawa, T
    Moriyama, M
    Shibahara, N
    Kaneko, M
    Suzuki, K
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Sugitani, M
    Suzuki, K
    Uchida, T
    Shikata, T
    GASTROENTEROLOGY, 1997, 112 (04) : A1378 - A1378
  • [6] Breakthrough and interferon dose in the therapy of chronic hepatitis C.
    Bellati, G
    Roffi, L
    Colloredo, G
    DAcquino, M
    Ricci, A
    Redaelli, A
    Tempini, S
    Bellobuono, A
    Bonino, F
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P97 - P97
  • [7] Glucose intolerance in poor response to interferon therapy in the patients with chronic hepatitis C.
    Kikuchi, I
    HEPATOLOGY, 2001, 34 (04) : 602A - 602A
  • [8] A simple score to predict response to interferon therapy in patients with chronic hepatitis C.
    Huet, C
    Salmi, LR
    Dumas, F
    Ledinghen, V
    Couzigou, P
    HEPATOLOGY, 1996, 24 (04) : 133 - 133
  • [9] Combination therapy with beta and alpha interferon in patients with interferon-resistant chronic hepatitis C.
    Watanabe, H
    Sakisaka, S
    HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [10] Antigen processing genes in the responsiveness to interferon therapy in the patients with chronic hepatitis C.
    Kikuchi, I
    Mihara, K
    Miyanaga, O
    Machidori, H
    Ishikawa, E
    Ueda, A
    HEPATOLOGY, 1998, 28 (04) : 573A - 573A
12345